Physician profile
Victory Eze
NPI 1376273201
$2,022.43
in general payments reported to CMS, 2019-2025
11 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $309 · 2024: $673 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,022.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $299.71 | 2023-2025 | Versawrap |
| Acera Surgical, INC. | $290.56 | 2023-2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $271.36 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $224.14 | 2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $215.64 | 2024 | |
| Polynovo North America LLC | $143.47 | 2023 | |
| Axogen | $140.53 | 2025 | |
| Heron Therapeutics, INC. | $121.86 | 2025 | Zynrelef, Aponvie |
| Checkpoint Surgical, INC | $108.21 | 2024 | Checkpoint Stimulators |
| Vertex Pharmaceuticals Incorporated | $104.32 | 2025 | |
| Abbvie INC. | $102.63 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victory Eze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.